Myelin and oligodendrocyte lineage cell dysfunctions: New players in the etiology and treatment of depression and stress-related disorders
- PMID: 31736197
- DOI: 10.1111/ejn.14621
Myelin and oligodendrocyte lineage cell dysfunctions: New players in the etiology and treatment of depression and stress-related disorders
Abstract
Depressive disorders are complex, multifactorial disorders that have been traditionally attributed exclusively to neuronal abnormalities. However, recent studies have increased our understanding of the contribution of glial cells-and particularly of oligodendroglia-to the pathogenesis and treatment outcome of depression and stress-related disorders. This review scrutinizes recent studies focusing on the neurosupportive functions exerted by myelin and oligodendrocyte lineage cells and their disruption in depression and stress-related disorders. It also illustrates how myelin and oligodendroglia respond to antidepressants and non-pharmacological treatment alternatives and proposes oligodendroglia-directed approaches as novel therapeutic options for depressive disorders.
Keywords: antidepressant; early life experience; myelination; neuromodulation.
© 2019 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
References
REFERENCES
- 
    - Alexopoulos, G. S., Kiosses, D. N., Choi, S. J., Murphy, C. F., & Lim, K. O. (2002). Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. American Journal of Psychiatry, 159, 1929-1932.
 
- 
    - Alonso, G. (2000). Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia, 31, 219-231. https://doi.org/10.1002/1098-1136(200009)31:3<219:AID-GLIA30>3.0.C...
 
- 
    - Anderson, R. J., Hoy, K. E., Daskalakis, Z. J., & Fitzgerald, P. B. (2016). Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections. Clinical Neurophysiology, 127, 3394-3405. https://doi.org/10.1016/j.clinph.2016.08.015
 
- 
    - Ansorge, M. S., Hen, R., & Gingrich, J. A. (2007). Neurodevelopmental origins of depressive disorders. Current Opinion in Pharmacology, 7, 8-17. https://doi.org/10.1016/j.coph.2006.11.006
 
- 
    - Arnett, P. A., Barwick, F. H., & Beeney, J. E. (2008). Depression in multiple sclerosis: Review and theoretical proposal. Journal of the International Neuropsychological Society, 14, 691-724. https://doi.org/10.1017/S1355617708081174
 
 
        
